国家医保局通报：医保结算过的药品，5天后在另一药店销售，现场突击检查后，抄出大量回流药

Core Viewpoint - The National Healthcare Security Administration (NHSA) has launched a nationwide special action to combat fraud and illegal activities in the pharmaceutical sector, utilizing drug traceability codes as a key tool, and has announced eight typical cases of violations [1]. Group 1: Cases of Fraudulent Activities - A case in Lanzhou, Gansu Province, involved a pharmacy selling drugs that had already been reimbursed by another pharmacy, indicating illegal resale of Medicare drugs. A total of 1,124 boxes of drugs, including high-value cancer treatment medications, were seized [2]. - Other cases include nine pharmacies in Wuhan, Hubei Province, involved in the resale of Medicare drugs; a pharmacy in Changsha, Hunan Province, that forged prescriptions; and a pharmacy in Fuzhou, Jiangxi Province, that swapped and resold Medicare drugs [3]. - Additional violations include a clinic in Hefei, Anhui Province, purchasing drugs from online platforms illegally; a pharmacy in Yangquan, Shanxi Province, inducing false purchases; and a doctor in Xi'an, Shaanxi Province, who prescribed excessive medications [3]. Group 2: Regulatory Actions and Warnings - The NHSA has emphasized that selling returned drugs is illegal and that traceability codes serve as a unique "electronic ID" for each drug. All Medicare-designated medical institutions must procure drugs with these codes and settle payments via scanning [3]. - Medicare beneficiaries are advised to use the national Medicare app to scan the traceability codes on drug packages and report any suspicious repeated settlements of returned drugs to protect their legal rights [3].